Stocks
Sino Biopharmaceutical Limited Financial Statements (SBMFF) |
||||||||||
| Sino Biopharmaceutical Limitedsmart-lab.ru | % | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2022 | 31.03.2023 | 30.06.2023 | 30.09.2023 | 31.12.2023 | 31.12.2023 | ||||
| Currency | CNY | CNY | CNY | CNY | CNY | CNY | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Assets, bln rub | 64 064 | 65 641 | 65 641 | 63 605 | 63 605 | 63 605 | ||||
| Net Assets, bln rub | ? | 29 747 | 29 989 | 29 989 | 30 474 | 30 474 | 30 474 | |||
| Debt, bln rub | 13 982 | 11 516 | 11 554 | 12 645 | 12 580 | 12 580 | ||||
| Cash, bln rub | 16 922 | 15 676 | 15 676 | 14 118 | 14 118 | 14 118 | ||||
| Net debt, bln rub | -2 940 | -4 160 | -4 122 | -1 473 | -1 538 | -1 538 | ||||
| Ordinary share price, rub | 0.585 | 0.520 | 0.391 | 0.340 | 0.416 | |||||
| Market cap, bln rub | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| EV, bln rub | ? | -2 940 | -4 160 | -4 122 | -1 473 | -1 538 | -1 538 | |||
| Book value, bln rub | 27 833 | 27 048 | 27 048 | 29 546 | 27 566 | 27 566 | ||||
| ROE, % | ? | 9.32% | 9.24% | 9.24% | 9.09% | 9.09% | 0 | |||
| ROA, % | ? | 4.33% | 4.22% | 4.22% | 4.36% | 4.36% | 0 | |||
| P/E | ? | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | ? | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/BV | ? | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | |||
| EV/EBITDA | ? | -0.60 | -0.85 | -0.84 | -0.30 | -0.31 | ||||
| Debt/EBITDA | -0.60 | -0.85 | -0.84 | -0.30 | -0.31 | |||||
| Sino Biopharmaceutical Limited shareholders | ||||||||||
